Twin Tree Management, LP Bluebird Bio, Inc. Transaction History

Twin Tree Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$59.47 - $93.1 $573,112 - $897,204	-9,637 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$75.84 - $105.21 $650,707 - $902,701	8,580 Added 811.73%	9,637 $1.23 Million
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $58,382 - $94,323	906 Added 600.0%	1,057 $166,000
Q4 2018 Feb 13, 2019	SELL	$59.1 - $93.26 $27,186 - $42,899	-460 Reduced 75.29%	151 $15,000
Q3 2018 Nov 09, 2018	SELL	$88.86 - $117.49 $927,787 - $1.23 Million	-10,441 Reduced 94.47%	611 $89,000
Q2 2018 Aug 08, 2018	BUY	$99.64 - $127.59 $377,635 - $483,566	3,790 Added 52.19%	11,052 $1.74 Million
Q1 2018 May 09, 2018	BUY	$105.8 - $150.94 $640,301 - $913,488	6,052 Added 500.17%	7,262 $1.24 Million
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $98,312 - $158,147	1,210	1,210 $216,000

112

61.5M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $485M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.